doi: 10.1016/j.lfs.2024.122699 461 YaakoubH.MinaS.CalendaA.BoucharaJ
Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, Mise S, Brcic I, Kolenc D, Klicek R, Banic T, Sever M, Kocijan A, Berkopic L, Radic B, Buljat G, Anic T, Zoricic I, Bojanic I, Seiwerth S, Sikiric P
10.1186/s12951-018-0392-8 J
A safety survey 3 of intranasal glutathione highlighted the mild side effects, including irritation of nasal passages and headaches
Circulating extracellular vesicles (EVs) derived from SCD patients, especially during acute chest syndrome (ACS) episodes, have been shown to disrupt endothelial barrier function